维普中文期刊产品整合服务
310篇 您的检索式:作者名="Wang AD"
    题名 作者 年代 出处 被引量
1Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres显示文摘BACKGROUND Mixed neuroendocrine non-neuroendocrine neoplasm(MiNEN)is a rare diagnosis,mainly encountered in the gastro-entero-pancreatic tract.There is limited knowledge of its epidemiology,prognosis and biology,and the best management for affected patients is still to be defined.AIM To investigate clinical-pathological characteristics,treatment modalities and survival outcomes of a retrospective cohort of patients with a diagnosis of MiNEN.METHODS Consecutive patients with a histologically proven diagnosis of MiNEN were identified at 5 European centres.Patient data were retrospectively collected from medical records.Pathological samples were reviewed to ascertain compliance with the 2017 World Health Organisation definition of MiNEN.Tumour responses to systemic treatment were assessed according to the Response Evaluation Criteria in Solid Tumours 1.1.Kaplan-Meier analysis was applied to estimate survival outcomes.Associations between clinical-pathological characteristics and survival outcomes were explored using Log-rank test for equality of survivors functions(univariate)and Cox-regression analysis(multivariable).RESULTS Sixty-nine consecutive patients identified;Median age at diagnosis:64 years.Males:63.8%.Localised disease(curable):53.6%.Commonest sites of origin:colon-rectum(43.5%)and oesophagus/oesophagogastric junction(15.9%).The neuroendocrine component was;predominant in 58.6%,poorly differentiated in 86.3%,and large cell in 81.25%,of cases analysed.Most distant metastases analysed(73.4%)were occupied only by a poorly differentiated neuroendocrine component.Ninety-four percent of patients with localised disease underwent curative surgery;53%also received perioperative treatment,most often in line with protocols for adenocarcinomas from the same sites of origin.Chemotherapy was offered to most patients(68.1%)with advanced disease,and followed protocols for pure neuroendocrine carcinomas or adenocarcinomas in equal proportion.In localised cases,median recurrence free survival(RFS);14.0 months(95%CI:9.2-24.4),and median overall survival(OS):28.6 months(95%CI:18.3-41.1).On univariate analysis,receipt of perioperative treatment(vs surgery alone)did not improve RFS(P=0.375),or OS(P=0.240).In advanced cases,median progression free survival(PFS);5.6 months(95%CI:4.4-7.4),and median OS;9.0 months(95%CI:5.2-13.4).On univariate analysis,receipt of palliative active treatment(vs best supportive care)prolonged PFS and OS(both,P<0.001).CONCLUSION MiNEN is most commonly driven by a poorly differentiated neuroendocrine component,and has poor prognosis.Advances in its biological understanding are needed to identify effective treatments and improve patient outcomes.Melissa Frizziero Xin Wang Bipasha Chakrabarty Alexa Childs Tu V Luong Thomas Walter Mohid S Khan Meleri Morgan Adam Christian Mona Elshafie Tahir Shah Annamaria Minicozzi Wasat Mansoor Tim Meyer Angela Lamarca Richard A Hubner Juan W Valle Mairéad G McNamara 2019World Journal of Gastroenterology2019,25,39:13
2Obesity-induced hypertension develops in young rats independently of the rennin-angiotensin-aldosterone system显示文摘Smith AD Brands MW Wang MH 2006Exp Biol Med2006,231,:1
3Chinese ischemic stroke subclassification显示文摘Gao S Wang YJ Xu AD 2011Front Neurol2011,2,:1
4Circulating levels of IL- l beta,a prothrombotic cytokine,are elevated in unstable angina versus stable angina显示文摘Simon AD Yazdani S Wang W 2000J Thromb Thrombolysis2000,9,3:1
5Connexin43 with a cytoplasmic loop deletion inhibits the function of several connexins显示文摘Wang M Martínez AD Berthoud VM 2005Biochem Biophys Res Commun2005,333,:1
6Angiotensin II in- creases urokinase-type plasminogen activator expression and in- duces aneurysm in the abdominal aorta of apolipoprotein E- deficient mice显示文摘Wang YX Martin- MeNulty B Freay AD 2001Am J Pathol2001,159,4:1
7Polylactic acid mesh recon- struction of the anterior iliac crest after bone harvesting reduces ear- ly postoperative pain after anterior cervical fusion surgery显示文摘Wang MY Levi AD Shah S 2002Neu- rosurgery2002,51,2:1
8Assessment of arterial stiffness, a translational medicine biomarker system for evaluation of vascular risk显示文摘Wang X Keith JC Struthers AD 2008Cardiovasc Ther2008,26,3:1
9Bilineal Disease and Trans-Heterozygotes in Autosomal Dominant Polycystic Kidney Disease显示文摘Pei Y Paterson AD Wang KR 2001Am J Hum Genet2001,68,:1
10A pooled analysis of gemcitabine plus docetaxel versus capecitabine plus docetaxel in metastatic breast cancer显示文摘Seidman AD Chan S Wang J 2014Oncologist2014,19,5:1
11The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression显示文摘Wang C Thor AD Moore DH 1998Clin Cancer Res1998,4,3:1
12Chinese ischemic stroke subclassification显示文摘Gao S Wang Y J Xu AD 2011Front Neurol2011,2,:1
13Chinese ischemic stroke subclas-sification显示文摘Gao S Wang YJ Xu AD 2011Front Neurol2011,2,6:1
14Chinese ischemic stroke subclassification 显示文摘Gao S Wang YJ Xu AD 2011Front Neuro12011,2,:1
15Chinese ischemic stroke subclassification显示文摘Gao S Wang YJ Xu AD 2011Front Neurol2011,15,:1
16Evolution of radiation-induced brain injury: MR imaging-based study 显示文摘Wang YX King AD Zhou H 2010Radiology2010,254,1:1
17Assessment of arterial stiffness, a translational medicine biomarker system for evaluation of vascular risk显示文摘Wang X Keith JC Jr Struthers AD 2008Cardiovase Ther2008,26,3:1
18Nitric oxide modulates fracture healing显示文摘Diwan AD Wang MX Jang D 2000J Bone Miner Res2000,15,2:1
19Chinese ischemic stroke subclassification 显示文摘GAO S WANG YJ XU AD 2011Front Neurol2011,15,2:1
20Cavitation clouds created by shock scattering from bubbles during histotripsy显示文摘Maxwell AD Wang TY Cain CA 2011J Acoust Soc Am2011,130,:1
返回顶部 每页显示:
共16页 首页 上一页 第1页 下一页 末页 /16 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费